We are live on !
Find out more
3C
361 Capital Portfolio holdings
AUM
$213M
Turnover
55.09%
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter Est. Return
+35.34%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$213M
AUM Growth
-$6.7M
(-3%)
Cap. Flow
-$47.5M
Cap. Flow % of AUM
Cap. Flow %
-22.27%
Top 10 Holdings %
Top 10 Hldgs %
8.05%
Holding
403
New
118
Increased
30
Reduced
151
Closed
104
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lear
LEA
|
+$1.16M |
| 2 |
Americold
COLD
|
+$1.09M |
| 3 |
Republic Services
RSG
|
+$1.07M |
| 4 |
Howmet Aerospace
HWM
|
+$1.07M |
| 5 |
Intercontinental Exchange
ICE
|
+$911K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chemed
CHE
|
+$1.96M |
| 2 |
Helen of Troy
HELE
|
+$1.64M |
| 3 |
FTI Consulting
FCN
|
+$1.55M |
| 4 |
Spire
SR
|
+$1.54M |
| 5 |
McKesson
MCK
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.91% |
| 2 | Technology | 16.4% |
| 3 | Miscellaneous | 12.97% |
| 4 | Financials | 12.03% |
| 5 | Industrials | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Regeneron Pharmaceuticals
REGN
$98.8B
| $956K | 0.45% |
1,533
-922
| -38% | -$523K |
2019 Q3
3 quarters
|
|
52
Kimberly-Clark
KMB
$67.2B
| $955K | 0.45% |
6,755
-1,363
| -17% | -$188K |
2020 Q1
1 quarter
|
|
53
Fox Class A
FOXA
$28.9B
| $950K | 0.45% |
35,413
-17,689
| -33% | -$478K |
2019 Q4
2 quarters
|
|
54
Sportsman's Warehouse
SPWH
$46.2M
| $943K | 0.44% |
+66,186
| New | +$622K |
2020 Q2
0 quarters
|
|
|
AAWW
55
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $935K | 0.44% |
21,720
-16,300
| -43% | -$572K |
2020 Q1
1 quarter
|
|
56
Dollar General
DG
$29.6B
| $932K | 0.44% |
4,890
-345
| -7% | -$62.4K |
2019 Q3
3 quarters
|
|
57
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$296M
| $931K | 0.44% |
30,508
+28
| +0.1% | +$839 |
2018 Q2
8 quarters
|
|
58
DELISTED
Esperion Therapeutics
ESPR
| $920K | 0.43% |
+17,936
| New | +$750K |
2020 Q2
0 quarters
|
|
59
Match Group
MTCH
$9.47B
| $913K | 0.43% |
8,532
-2,798
| -25% | -$234K |
2020 Q1
1 quarter
|
|
|
60
Intercontinental Exchange
ICE
$100B
| $911K | 0.43% |
+9,949
| New | +$911K |
2020 Q2
0 quarters
|
|
61
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $911K | 0.43% |
23,482
-74
| -0.3% | -$2.7K |
2018 Q2
8 quarters
|
|
|
ATNX
62
DELISTED
Athenex, Inc. Common Stock
ATNX
| $909K | 0.43% |
3,304
-514
| -13% | -$109K |
2020 Q1
1 quarter
|
|
63
Jack Henry & Associates
JKHY
$12.4B
| $907K | 0.43% |
4,929
-2,995
| -38% | -$522K |
2020 Q1
1 quarter
|
|
64
DELISTED
The Shyft Group
SHYF
| $906K | 0.42% |
53,819
-8,401
| -14% | -$127K |
2020 Q1
1 quarter
|
|
65
Murphy USA
MUSA
$9.8B
| $901K | 0.42% |
+8,005
| New | +$877K |
2020 Q2
0 quarters
|
|
66
Procter & Gamble
PG
$394B
| $900K | 0.42% |
7,525
-1,456
| -16% | -$170K |
2019 Q1
5 quarters
|
|
67
Bank of New York Mellon
BNY
$103B
| $894K | 0.42% |
+23,126
| New | +$846K |
2020 Q2
0 quarters
|
|
68
Addus HomeCare
ADUS
$2.29B
| $893K | 0.42% |
9,645
-1,496
| -13% | -$129K |
2019 Q2
4 quarters
|
|
69
Calix
CALX
$1.99B
| $889K | 0.42% |
+59,646
| New | +$685K |
2020 Q2
0 quarters
|
|
70
SiteOne Landscape Supply
SITE
$4.86B
| $886K | 0.42% |
+7,771
| New | +$722K |
2020 Q2
0 quarters
|
|
71
Travere Therapeutics
TVTX
$4.86B
| $886K | 0.42% |
+43,408
| New | +$691K |
2020 Q2
0 quarters
|
|
72
CVS Health
CVS
$114B
| $885K | 0.41% |
+13,628
| New | +$858K |
2020 Q2
0 quarters
|
|
73
Alarm.com
ALRM
$3.21B
| $884K | 0.41% |
13,643
-2,119
| -13% | -$107K |
2020 Q1
1 quarter
|
|
74
Wingstop
WING
$4.3B
| $883K | 0.41% |
+6,351
| New | +$740K |
2020 Q2
0 quarters
|
|
75
Ultra Clean Holdings
UCTT
$2.22B
| $882K | 0.41% |
38,980
-6,062
| -13% | -$115K |
2020 Q1
1 quarter
|
|
Similar funds
RCM
RI
361 Capital's Q2 2020 Portfolio in Review
As of Q2 2020, 361 Capital held 403 positions worth $213M, down 3% from $220M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
361 Capital withdrew a net $47.5M in Q2 2020, closing 104 positions and reducing 151 holdings. Its most notable exit was Chemed, an estimated $1.96M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, 361 Capital opened a new position in Lear worth $1.27M.
- 361 Capital's largest Q2 2020 buy was Lear: 11,650 shares worth $1.27M.
- 361 Capital added most to DaVita in Q2 2020, an estimated $427K increase.
- 361 Capital's biggest Q2 2020 reduction was Williams Companies, cutting an estimated $1.41M.
- 361 Capital fully exited Chemed in Q2 2020, selling an estimated $1.96M.
- 361 Capital's ten largest holdings make up 8.1% of its $213M portfolio in Q2 2020.
- 361 Capital opened 118 new positions and closed 104 in Q2 2020.
- 361 Capital's portfolio value fell 3% quarter-over-quarter to $213M.
Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.